US Stock MarketDetailed Quotes

BridgeBio Pharma (BBIO)

Watchlist
  • 68.250
  • +0.570+0.84%
Trading Jun 10 10:38 ET
13.37BMarket Cap-18.25P/E (TTM)

BridgeBio Pharma (BBIO) Earnings Dates, Reports & Conference Call

BBIO 2026 Q1 Earnings Dates & Summary

Currency:USDMay 7, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
178.61M
194.52M
+15.90M
Beat Est.
+53.14%
+66.78%
+8.90%
Net Income
-130.27M
-164.04M
-33.78M
Miss Est.
+22.19%
+2.02%
-25.93%
Strong Buy

Jun 10, 2026

BBIO Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 19 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q3-- / 253.864M--
--2026/Q2-- / 225.379M--
May 7, 20262026/Q1194.515M / 178.611M--
Feb 24, 20262025/Q4154.178M / 149.073M--
Oct 29, 20252025/Q3120.700M / 106.081M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q3-- / 253.864M--
--2026/Q2-- / 225.379M--
May 7, 20262026/Q1194.515M / 178.611M--
Feb 24, 20262025/Q4154.178M / 149.073M--
Oct 29, 20252025/Q3120.700M / 106.081M--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East are escalating: Iran shot down a U.S. Apache helicopter, prompting retaliatory U.S. airstrikes on multiple locat Show More